Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Asset Utilization Ratio: 2019-2025

Historic Asset Utilization Ratio for Arcturus Therapeutics Holdings (ARCT) over the last 6 years, with Sep 2025 value amounting to 0.33.

  • Arcturus Therapeutics Holdings' Asset Utilization Ratio fell 21.91% to 0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year decrease of 21.91%. This contributed to the annual value of 0.39 for FY2024, which is 3.87% up from last year.
  • As of Q3 2025, Arcturus Therapeutics Holdings' Asset Utilization Ratio stood at 0.33, which was down 13.40% from 0.38 recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Asset Utilization Ratio ranged from a high of 0.67 in Q3 2023 and a low of 0.02 during Q2 2021.
  • In the last 3 years, Arcturus Therapeutics Holdings' Asset Utilization Ratio had a median value of 0.42 in 2024 and averaged 0.45.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Asset Utilization Ratio tumbled by 92.39% in 2021 and then soared by 1,753.49% in 2022.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Asset Utilization Ratio (Quarterly) stood at 0.03 in 2021, then surged by 1,753.49% to 0.55 in 2022, then tumbled by 32.09% to 0.38 in 2023, then climbed by 13.33% to 0.43 in 2024, then dropped by 21.91% to 0.33 in 2025.
  • Its last three reported values are 0.33 in Q3 2025, 0.38 for Q2 2025, and 0.43 during Q1 2025.